Get the Stockscreener App
2.03
2.53%
0.05
After Hours:
2.04
0.01
+0.49%
Stereotaxis Inc stock is traded at $2.03, with a volume of 478.65K.
It is up +2.53% in the last 24 hours and down -20.39% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$1.98
Open:
$2.03
24h Volume:
478.65K
Relative Volume:
0.82
Market Cap:
$189.45M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-7.5185
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
-7.31%
1M Performance:
-20.39%
6M Performance:
-9.78%
1Y Performance:
-16.80%
1-Day Range:
$1.98
$2.06
1-Week Range:
$1.98
$2.265
52-Week Range:
$1.54
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.03 | 184.78M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
488.15 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
210.02 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
271.63 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.30 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
78.83 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Trade Recap: What are the risks of holding Stereotaxis IncMarket Activity Report & Accurate Trade Setup Notifications - baoquankhu1.vn
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 1.6%Here's What Happened - MarketBeat
Stereotaxis Bets On New Catheters To Turn Its Niche Into Growth - Finimize
Retail Trends: What are the risks of holding Stereotaxis Inc2025 Growth vs Value & Weekly High Conviction Ideas - baoquankhu1.vn
Will Stereotaxis Inc outperform the market in YEARJuly 2025 Technicals & Community Consensus Stock Picks - baoquankhu1.vn
Should value investors consider Stereotaxis IncEarnings Overview Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Why Stereotaxis Inc. stock is popular among millennialsEarnings Trend Report & Verified Entry Point Detection - bollywoodhelpline.com
da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles? - Nasdaq
Insider Sell: Is Stereotaxis Inc stock resilient to inflationQuarterly Risk Review & Consistent Profit Focused Trading Strategies - Bộ Nội Vụ
Robotics in EP and Cath Labs - Diagnostic and Interventional Cardiology
What sentiment indicators say about Stereotaxis Inc. stockPortfolio Return Report & Accurate Intraday Trading Signals - Улправда
Is Stereotaxis Inc. stock cheap by valuation metricsJuly 2025 Institutional & Technical Buy Zone Confirmations - Улправда
Is Stereotaxis Inc. stock positioned for digital transformationJuly 2025 Chart Watch & Long Hold Capital Preservation Tips - Улправда
St. Louis-based Stereotaxis gets FDA nod for robotic heart device central to growth strategy - The Business Journals
How Stereotaxis Inc. stock performs during Fed tightening cyclesEarnings Per Share Trends & Big Returns, Small Investment – Learn How - Улправда
Analysts Offer Insights on Healthcare Companies: Candel Therapeutics (CADL) and Stereotaxis (STXS) - The Globe and Mail
Stereotaxis wins FDA approval for robotically navigated ablation catheter - MedTech Dive
Stereotaxis (NYSEAMERICAN:STXS) Trading 8.1% HigherWhat's Next? - MarketBeat
Stereotaxis’ Magic magnetic ablation gets FDA nod - BioWorld MedTech
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):